Endometriosis Research

Endometriosis isn’t one uniform condition, so study results can vary depending on which lesion types and locations are included, how advanced disease is, and whether participants have had prior hormonal treatment or surgery. Many studies also rely on small or highly selected groups, which can make findings look stronger (or weaker) than they are in real-world patients.

On top of that, research teams may use different diagnostic standards, define outcomes differently (pain scores vs quality of life vs fertility), and follow patients for different lengths of time—so they’re not always measuring the same thing. When we interpret research with patients, we look for results that hold up across larger, more diverse groups and, when possible, well-designed randomized trials, because that’s more likely to reflect what you can expect in care.

Researchers are studying new, non-hormonal treatments for endometriosis that aim to treat the disease biology itself—not just suppress cycles. Current trials include medications designed to reduce inflammation, calm nerve sensitization (pain signaling), limit new blood vessel growth (angiogenesis), and address scarring and fibrosis.

There’s also growing interest in how the microbiome and immune system may influence symptoms and progression, which could shape future therapies. While a few approaches look promising, most are still experimental and not widely available outside of clinical trials. If you’re curious about what’s in the pipeline and what may be appropriate for your situation, our team can help you understand where emerging therapies fit alongside proven options like expert excision surgery and individualized medical management.

A well-designed clinical trial can be a good fit if you want access to an investigational therapy and are comfortable contributing to research that may improve endometriosis care. At the same time, trials often involve randomization (and sometimes placebo), stricter protocols, additional visits, and rules about what other treatments you can use during the study.

Before enrolling, it’s important to understand exactly what the study requires and how it could affect your overall plan—especially if you’re considering surgery, trying to preserve or pursue fertility, or managing symptoms with medications. Our team can help you weigh the potential benefits against the time commitment, risks, and likelihood that the trial will answer the questions that matter most for your case, and help you think through what to ask the study coordinators before you decide.

Biomarkers are promising, but they’re not yet a reliable way to choose a specific endometriosis treatment or to measure, in real time, how well a therapy is working. In research settings, multi-marker panels may eventually help stratify inflammation or disease activity and support more individualized decisions about hormonal suppression, pain management strategies, or the timing of excision.

Right now, the most dependable way we monitor response is still how you feel and function over time, paired with clinical evaluation and imaging when appropriate. In select situations—such as monitoring a large endometrioma—your team may follow a lab like CA-125 as one piece of the picture, but it’s not specific enough to use alone. If you’re interested in whether biomarker testing could add value in your case, our team can walk you through what’s available, what it can and can’t tell us, and how we’d use it alongside symptoms and imaging.

A safe way to start is by using reputable trial registries (such as ClinicalTrials.gov) to confirm a study is real and to review the basics: the trial phase, what treatment is being tested, the primary outcomes, and the eligibility criteria. We also encourage you to look closely at what participation actually involves—extra visits, imaging, biopsies, medication changes, or washout periods—so you can weigh the time and symptom impact alongside potential benefit. Many trials do cover study-related costs, but coverage varies, so it’s important to clarify what is paid for, what might be billed to insurance, and any travel or time-off burdens.

To judge the “hype,” focus on the quality of the evidence rather than headlines or social media summaries. Peer-reviewed publication helps, but we also look for whether the study design and sample size are strong enough to support the claims and whether the outcomes are truly meaningful for patients (pain, daily function, and quality of life—not just lab markers). If you’d like, our team can help you interpret a trial listing or a published paper in the context of your symptoms and goals and discuss whether a study is a reasonable fit for you.

Genetics may change endometriosis treatment by helping us understand the biological pathways that drive pain, inflammation, and lesion behavior. As those pathways become clearer, researchers can develop more targeted, potentially non-hormonal medications designed for specific mechanisms rather than one-size-fits-all symptom control.

In the near term, the biggest impact is likely improved risk stratification and biomarker development—tools that could help predict who is more likely to have endometriosis, how aggressive it may be, or which approaches might be most effective. Most genetics-guided “precision” treatments are still in development, but our team stays closely aligned with this research and can discuss what’s realistic now versus what may be on the horizon when you meet with us.